Skip to content

Relationship Between Pressure Pain Threshold and Pain Intensity, Affect and Disability in CLBP

CompletedNot applicableNCT04482075
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

The association between pressure pain threshold and different aspects of low back pain has garnered attention over the years. However, since most of such studies in the past employed cross sectional designs, a longitudinal study design with follow-up measurements is required to further investigate this relationship. Studying this relationship will not only offer insights into the phenomenon of pain but may also bring us one step closer to achieving the seemingly insurmountable goal of objectively measuring back pain and its different dimensions.

Study details

Official title
Cross-modality Matching Between Pressure Pain Threshold and Subjective Ratings of Pain Intensity, Affect and Disability in Patients With Chronic Low Back Pain.
Conditions
Interventions
  • Other: segmental stability training
Sponsor
Dow University of Health Sciences
Start date
2019-07-01
Primary completion
2020-12-23
Sex
Male
Age range
from 18 Years to 50 Years
Results posted
No results posted in this snapshot
Countries
Pakistan
Total sites listed
1

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Adult males with low back pain with an age group of 18-50 years. Exclusion Criteria: 1. Individuals having low back pain for less than 3 months. 2. Individuals with specific underlying pathology as the cause of CLBP. (Active oncological disease, Known disc derangement, cauda equina syndrome, spinal trauma i.e. fracture, neuropathy i.e. sciatica or severe root compression, spinal structural deformity, infection, inflammatory joint disease, spinal stenosis, spondylolysis, spondylolisthesis). 3. Individuals having neurological diseases (including central and peripheral diseases); metabolic diseases (i.e. diabetes and hypothyroidism); coagulopathies (i.e. haemophilia). 4. Individuals with fibromyalgia syndrome (FMS); myofascial pain syndrome (MPS); allodynia (stroking hyperalgesia). 5. Individuals suffering from aphasia or suffering from deafness, blindness or muteness. 6. Individuals with skin disease (i.e. psoriasis, scleroderma, leprosy, etc.) or skin lesions (i.e. abrasion/laceration/ bruise) in the low back region. 7. Individuals having oral temperature of 100 F or above. 8. Individuals who have undergone spinal surgery. 9. Individuals scoring 28+ for depression, 20+ for anxiety, 34+ for stress on DASS-21. 10. Individuals in whom prone lying causes significant discomfort (i.e. dyspnoea etc.). 11. Individuals who do not perceive pressure pain below 10 kg/cm2 during PPT testing. 12. Individuals evincing bruising to PPT testing.

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04482075